ACTR-79. ESTABLISHMENT OF CLINICAL PROTOCOL TARGETING CANCER STEM CELLS IN RECURRENT GLIOBLASTOMA USING HIGH-THROUGHPUT DRUG SCREENING

Despite aggressive multimodal oncological treatment, glioblastoma (GBM) disease progresses within 10 months. Due to the lack of treatment options for the relapsed disease, enrollment in clinical trials may be the best option. However, the fundamental preclinical studies leading to clinical investiga...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Skaga, Erlend, Kulesskiy, Evgeny, Brynjulfsen, Marit, Sandberg, Cecilie Jonsgar, Kyttälä, Aija, Langmoen, Iver Arne, Laakso, Aki, Gaál-Paavola, Emília, Perola, Markus, Wennerberg, Krister, Vik-Mo, Einar Osland
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692302/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.066
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados